Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: BARUCH S. BLUMBERG INSTITUTE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-11-15 to 2024-05-31
Current total value of award: $5493876
Description: TO DEVELOP AN ORALLY AVAILABLE SMALL MOLECULE ANTIVIRAL DRUG, WITH TREATMENT OF YELLOW FEVER VIRUS INFECTION AS THE PRIMARY INDICATION.